P2RX7 and cancer: Given that P2X7 is a major positive regulator of the NLRP3 pathway [70], it is tempting to speculate that at list part of Foxp3 positive cells could belong to the subclass of Foxp3+ RORγt + IL17+ cells which were recently associated with NLRP3 activation in cancer [71].